angiotensin ii has been researched along with thiamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nunnally, ME; Patel, A | 1 |
| Evans, H; Ho, VP; Kaafarani, H; Namias, N; Rattan, R; Zakrison, TL | 1 |
| Bonderski, V; Krishnan, K; Rech, MA; Tednes, P; Wassermann, TB | 1 |
| Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
4 review(s) available for angiotensin ii and thiamine
| Article | Year |
|---|---|
Sepsis - What's new in 2019?
Topics: Angiotensin II; Anti-Bacterial Agents; Ascorbic Acid; Biomarkers; Combined Modality Therapy; Critical Care; Fluid Therapy; Glucocorticoids; Humans; Practice Guidelines as Topic; Procalcitonin; Resuscitation; Sepsis; Thiamine; Treatment Outcome | 2019 |
Sepsis 2019: What Surgeons Need to Know.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Angiotensin II; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Multiple, Bacterial; Duration of Therapy; Enterobacteriaceae Infections; Enterococcus faecium; Enzyme Inhibitors; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Methicillin-Resistant Staphylococcus aureus; Methylene Blue; Organ Dysfunction Scores; Patient Care Bundles; Postoperative Complications; Practice Guidelines as Topic; Procalcitonin; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Shock, Septic; Staphylococcal Infections; Thiamine; Vancomycin-Resistant Enterococci; Vasoconstrictor Agents; Vitamin B Complex | 2020 |
Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients.
Topics: Angiotensin II; Ascorbic Acid; Crystalloid Solutions; Disease Management; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Hydrocortisone; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Simendan; Thiamine | 2022 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |